Clinical Trial Update: TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating psilocybin-assisted psychotherapy for depression and anxiety in cancer survivors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Cancer
• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Depression, Anxiety | Phase 2 | Status: RECRUITING